```html

Yeast Infection (Candidiasis) – A Comprehensive Medical Guide

Overview

Candidiasis is an infection caused by an overgrowth of the fungus Candida, most commonly Candida albicans. The organism normally lives in small numbers on the skin, mouth, gastrointestinal tract, and genital area without causing problems. When the delicate balance of the body’s microbiome is disturbed, Candida can multiply and lead to infection.

Yeast infections affect people of all ages, sexes, and ethnicities. Global prevalence estimates vary by site of infection:

• Vulvovaginal candidiasis: up to 75 % of women will experience at least one episode in their lifetime; about 40–45 % have recurrent infections (≥ 4 episodes/year) (CDC, 2023).
• Oral thrush: occurs in 5–7 % of healthy adults but is far more common in infants, the elderly, and immunocompromised patients.
• Invasive candidiasis (bloodstream or deep‑tissue infection): ~ 750,000 cases worldwide each year, with a mortality rate of 30–40 % if not treated promptly (WHO, 2022).

Symptoms

Symptoms differ depending on the body site involved. Below is a complete list organized by the most common forms of candidiasis.

Vulvovaginal Candidiasis (VVC)

• Itching or burning of the vulva and vagina.
• Redness, swelling or soreness of the external genitalia.
• White, clumpy discharge that resembles cottage cheese; typically odorless.
• Pain during intercourse (dyspareunia) or urination.

Oral Thrush

• White or yellowish plaques on the tongue, inner cheeks, gums, or palate.
• Red, sore areas underneath the plaques that may bleed when scraped.
• Difficulty swallowing or a feeling of food “sticking” in the throat.
• Loss of taste or a cotton‑mouth sensation.

Diaper Rash (Infant Candidiasis)

• Bright red patches with well‑defined borders.
• Satellite lesions—small red spots surrounding the main rash.
• Fever or irritability only in severe cases.

Cutaneous (Skin) Candidiasis

• Red, moist, often “macaroni‑and‑cheese” rash in skin folds (groin, under breasts, between fingers).
• Itching, burning, or a “pimple‑like” appearance.
• Possible fissures or cracks that ooze fluid.

Invasive Candidiasis

• Persistent fever that does not improve with antibiotics.
• Chills, rapid heart rate, low blood pressure.
• Organ‑specific signs: abdominal pain (hepatic), visual changes (endophthalmitis), urinary symptoms (candiduria).

Causes and Risk Factors

What causes candidiasis? The infection results when Candida proliferates beyond its normal limits. Key mechanisms include:

• Disruption of the normal bacterial flora (e.g., after antibiotics).
• Impaired immune defenses (e.g., HIV, chemotherapy, steroids).
• Elevated blood sugar levels that provide a nutrient‑rich environment for yeast.
• Moist, warm environments that favor fungal growth.

Major Risk Factors

Factor	Why It Increases Risk
Antibiotic use (especially broad‑spectrum)	Reduces protective Lactobacillus species, allowing Candida to overgrow.
Diabetes mellitus	High glucose in blood and tissues feeds yeast; also impairs neutrophil function.
Pregnancy	Hormonal changes raise glycogen in vaginal tissues, creating a favorable substrate.
Immunosuppression (HIV, transplant, steroids)	Weakened cell‑mediated immunity cannot control fungal proliferation.
Hormonal contraception or hormone replacement therapy	Estrogen promotes vaginal glycogen, facilitating yeast growth.
High‑fat, high‑sugar diet	May alter gut microbiome and increase systemic glucose availability.
Tight, non‑breathable clothing	Creates warm, moist microclimates on skin folds.
Use of intrauterine devices (IUDs) or spermicides	Local irritation and changes in vaginal pH can predispose.

Diagnosis

Accurate diagnosis hinges on a combination of clinical evaluation and laboratory testing.

Clinical Evaluation

• Detailed history (symptom onset, frequency, medication use, underlying conditions).
• Physical examination of the affected area.

Laboratory Tests

• Microscopy & KOH prep: A sample of discharge or skin scrapings mixed with potassium hydroxide reveals yeast cells and pseudohyphae under a microscope.
• Culture: Growth on Sabouraud agar confirms species; essential for recurrent or resistant infections.
• PCR or DNA hybridization: Rapid identification, increasingly used for invasive disease.
• Vaginal pH test: A pH > 4.5 suggests bacterial vaginosis rather than candidiasis (VVC typically has normal pH).
• Blood cultures: Required for suspected invasive candidemia.
• Complete blood count (CBC) and inflammatory markers: Helpful in systemic infection.

Treatment Options

Treatment is tailored to the site of infection, severity, and patient-specific factors.

Topical Antifungals

• Clotrimazole, miconazole, terconazole creams or suppositories (usually 1–7 days).
• Effective for uncomplicated VVC, oral thrush, and skin candidiasis.

Oral Antifungals

• Fluconazole 150 mg single dose (or 100 mg daily for 3 days) – first‑line for VVC and many skin infections.
• Itraconazole or voriconazole for fluconazole‑resistant strains.
• Longer courses (2–6 weeks) may be needed for chronic or recurrent disease.

Intravenous Therapy (Invasive Candidiasis)

• Echinocandins (caspofungin, micafungin, anidulafungin) – preferred initial agents per IDSA guidelines.
• Step‑down to fluconazole once the isolate is proven susceptible.
• Therapy duration: generally 14 days after blood cultures become negative and clinical improvement occurs.

Adjunctive Measures

• Probiotic supplementation (Lactobacillus rhamnosus GG, L. reuteri) may help restore normal flora, especially after antibiotics.
• Address underlying diabetes or hormonal issues.
• For recurrent VVC, a maintenance regimen (e.g., weekly fluconazole) for 6 months is recommended.

Living with Yeast Infection (Candidiasis)

Even after successful treatment, many patients experience anxiety about recurrence. The following tips help maintain comfort and reduce flare‑ups.

• Keep affected areas dry: Change out of wet clothing promptly, use absorbent powders (talc‑free) in skin folds.
• Wear breathable fabrics: Cotton underwear, loose‑fitting clothing, and moisture‑wicking athletic wear.
• Practice good genital hygiene: Gentle, fragrance‑free cleansers; avoid douching or scented tampons.
• Manage blood sugar: Aim for HbA1c < 7 % if diabetic; regular monitoring can cut recurrence risk by up to 30 % (NIH, 2021).
• Limit unnecessary antibiotic use: Discuss alternatives with your clinician.
• Dietary considerations: Some patients report fewer episodes when reducing refined sugars and yeast‑containing foods, although evidence is mixed.
• Schedule follow‑up: After a first infection, see a provider if symptoms persist beyond 7 days of treatment or recur frequently.

Prevention

Prevention focuses on minimizing conditions that allow Candida to thrive.

• Maintain a healthy microbiome: Probiotics during/after antibiotics; consider a diet rich in fiber and fermented foods.
• Control glucose: Follow diabetic management plans; keep urinary output adequate.
• Personal hygiene: Wash with lukewarm water, pat dry; avoid scented soaps and bubble baths.
• Safe sexual practices: Use condoms if partner has a yeast infection; avoid sexual activity until symptoms resolve.
• Clothing choices: No tight jeans, synthetic underwear, or prolonged damp swimwear.
• Pregnancy care: Discuss any recurrent infections with obstetricians early; topical therapy is generally safe.
• Immunocompromised patients: Daily antifungal prophylaxis (e.g., fluconazole 100 mg weekly) may be prescribed per hematology/oncology guidelines.

Complications

If left untreated, candidiasis can lead to serious health problems.

• Chronic or recurrent VVC: May cause persistent discomfort, dyspareunia, and impact quality of life.
• Esophageal candidiasis: Can cause pain swallowing and predispose to aspiration pneumonia.
• Invasive candidiasis: Sepsis, organ failure, and a mortality rate up to 40 % in ICU patients.
• Complications in neonates: Oral or diaper candidiasis can progress to systemic infection in pre‑term infants.
• Impaired wound healing: Cutaneous candidiasis in surgical sites may delay closure.

When to Seek Emergency Care

For non‑emergent concerns, schedule an appointment with your primary‑care provider, OB‑GYN, dermatologist, or infectious‑disease specialist as appropriate.

---

Sources: Centers for Disease Control and Prevention (CDC). 2023. Vulvovaginal Candidiasis. ; Mayo Clinic. 2024. Yeast infection (vaginal). ; National Institutes of Health (NIH). 2021. Diabetes and fungal infections. ; World Health Organization (WHO). 2022. Invasive Fungal Diseases. ; Cleveland Clinic. 2024. Candidiasis Treatment Guidelines.

```